Loading
A haematologist who heads the Ribeirão Preto blood centre behind Brazil's national CAR-T programme, and a researcher on inherited telomere diseases.
Rodrigo Calado is director-president of the Fundação Hemocentro de Ribeirão Preto, as the centre's own page names him in October 2026, writing with Phillip Scheinberg that Brazil must train treating centres in every region now if its national CAR-T is to reach patients of the public health system. In 2022 Agência FAPESP quoted him, then the Hemocentro's scientific director, on the aim of a CAR-T costing 10 to 15 per cent of market prices. His research is on telomere biology disorders: he was an author of the 2016 New England Journal of Medicine trial of danazol in telomere diseases and senior author of a 2024 Blood study of clonal haematopoiesis and cancer mutations in those disorders. He is a co-author of the 2024 report of the first 20 patients treated with the centre's academic CD19 CAR-T cell.
| Title | Journal | Year |
|---|---|---|
| Safety and efficacy of a new academic CD19-directed CAR-T cell for refractory/relapsed non-Hodgkin lymphoma and acute lymphoblastic leukemia in Brazil | Bone Marrow Transplantation | 2024 |
| Clonal landscape and clinical outcomes of telomere biology disorders: somatic rescue and cancer mutations | Blood | 2024 |
| Danazol Treatment for Telomere Diseases | New England Journal of Medicine | 2016 |
Shares Safety and efficacy of a new academic CD19-directed CAR-T cell for refractory/relapsed non-Hodgkin lymphoma and acute lymphoblastic leukemia in Brazil, CD19-directed CAR-T cell therapy for refractory or relapsed acute lymphoblastic leukaemia or non-Hodgkin lymphoma (CARTHEDRALL), Fundação Hemocentro de Ribeirão Preto, CAR-T cell therapy and the tags clinician-scientist, cell-therapy.
Shares Manufacturing cost and time for living and radioactive medicines, CAR-T cell therapy and the tags clinician-scientist, cell-therapy.
Shares Manufacturing cost and time for living and radioactive medicines, CAR-T cell therapy and the tags clinician-scientist, cell-therapy.
Shares the tags leadership, clinician-scientist.
Shares the tags leadership, clinician-scientist.
Shares the tags leadership, clinician-scientist.
Shares the tags leadership, clinician-scientist.
Shares the tags leadership, clinician-scientist.
Every source this page cites, grouped by who published it. Grouping is read from the web address, not assigned by hand.
A source that has moved or gone is reported by the weekly link check. /audit/